When patients request the impotence pill: Tips for office evaluation and treatment

Postgraduate Medicine

Volumn 104, Issue 2, 1998, Pages 55-66

  Mobley, David F ^a   Baum, Neil ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; BARBITURIC ACID DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DISULFIRAM; HISTAMINE H2 RECEPTOR ANTAGONIST; NEUROLEPTIC AGENT; PHENYLEPHRINE; PLACEBO; PROSTAGLANDIN E1; PROSTAVASIN; PSEUDOEPHEDRINE; SEDATIVE AGENT; SILDENAFIL; TERBUTALINE; TERBUTALINE SULFATE; TRANQUILIZER; YOHIMBINE;

ANXIETY; ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; COLOR VISION DEFECT; COMPRESSION THERAPY; DEVICE; DOSE RESPONSE; FLUSHING; GASTROINTESTINAL TOXICITY; GENERAL PRACTITIONER; HEADACHE; HUMAN; HYPOTENSION; IMPOTENCE; INTRACAVERNOUS DRUG ADMINISTRATION; INTRAURETHRAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PENIS ERECTION; PREVALENCE; PRIAPISM; SIDE EFFECT; URETHRA DISEASE; VERTIGO;

EID: 0031844152     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1998.08.561     Document Type: Article

References (10)

1. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151(1):54-61
2. Boolell M, Allen MJ, Ballard SA, et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996;8(2):47-52
3. Goldstein I, Lue TF, Padma-Nathan H, et al, for the Sildenafil Study Group. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998;338(20): 1397-404
4. Morales A, Condra M, Owen JA, et al. Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial. J Urol 1987;137(6):1168-72
5. Randrup E, Wilson S, Mobley D, et al. Clinical experience with Mentor Alpha I inflatable penile prosthesis: report on 333 cases. Urology 1993;42(3):305-8
6. Linet OI, Ogrinc FG, for the Alprostadil Study Group. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med 1996; 334(14):873-7
7. Padma-Nathan H, Hellstrom WJ, Kaiser FE, et al, for the Medicated Urethral System for Erection (MUSE) Study Group. Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med 1997;336(1):1-7
8. Govier FE, Jonsson E, Kramer-Levien D. Oral terbutaline for the treatment of priapism. J Urol 1994;151(4):878-9
9. Becker AJ, Stief CG, Machtens S, et al. Oral phentolamine as treatment for erectile dysfunction. J Urol 1998;159(4): 1214-6
10. Heaton JP, Morales A, Adams MA, et al. Recovery of erectile function by the oral administration of apomorphine. Urology 1995;45(2):200-6